Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 1
1996 2
1997 1
1998 6
1999 14
2000 29
2001 19
2002 21
2003 23
2004 25
2005 33
2006 32
2007 22
2008 16
2009 15
2010 18
2011 19
2012 17
2013 21
2014 19
2015 11
2016 6
2017 16
2018 21
2019 19
2020 17
2021 21
2022 14
2023 21
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Results by year

Filters applied: . Clear all
Page 1
Zaleplon.
[No authors listed] [No authors listed] 2023 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000323 Free Books & Documents. Review.
Little information is available on the use of zaleplon during breastfeeding. A safety scoring system finds zaleplon to be not recommended during breastfeeding.[1] However, the low levels of zaleplon in breastmilk and its short half-life indicate that amounts …
Little information is available on the use of zaleplon during breastfeeding. A safety scoring system finds zaleplon to be not …
Zaleplon.
[No authors listed] [No authors listed] 2018 Feb 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Feb 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644230 Free Books & Documents. Review.
Zaleplon is a benzodiazepine receptor agonist and hypnotic that is used as a sleeping pill. Zaleplon has not been implicated in causing serum enzyme elevations or clinically apparent liver injury....
Zaleplon is a benzodiazepine receptor agonist and hypnotic that is used as a sleeping pill. Zaleplon has not been implicated i …
Zaleplon.
Bhandari P, Sapra A. Bhandari P, et al. 2023 Jun 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31855398 Free Books & Documents.
Insomnia is defined as the presence of long sleep latency, frequent nocturnal awakenings, or prolonged periods of wakefulness during the sleep period, or even frequent transient arousals. Zaleplon is a medication used in the management and treatment of insomnia. ...This ac …
Insomnia is defined as the presence of long sleep latency, frequent nocturnal awakenings, or prolonged periods of wakefulness during the sle …
Zaleplon: a review of its use in the treatment of insomnia.
Dooley M, Plosker GL. Dooley M, et al. Drugs. 2000 Aug;60(2):413-45. doi: 10.2165/00003495-200060020-00014. Drugs. 2000. PMID: 10983740 Review.
Zaleplon is a pyrazolopyrimidine hypnotic agent which is indicated for the short term (2 to 4 weeks) management of insomnia. ...The psychomotor profile of zaleplon appears to be better than that of comparator agents. Rebound insomnia was not observed after sudden di …
Zaleplon is a pyrazolopyrimidine hypnotic agent which is indicated for the short term (2 to 4 weeks) management of insomnia. ...The p …
Insomnia Management: A Review and Update.
Shaha DP. Shaha DP. J Fam Pract. 2023 Jul;72(6 Suppl):S31-S36. doi: 10.12788/jfp.0620. J Fam Pract. 2023. PMID: 37549414 Free PMC article. Review.
Pharmacologic agents that are approved by the US Food and Drug Administration for insomnia include benzodiazepine receptor agonists (zolpidem, eszopiclone, and zaleplon), low-dose doxepin (tricyclic antidepressant), ramelteon (melatonin receptor agonist), and dual orexin r …
Pharmacologic agents that are approved by the US Food and Drug Administration for insomnia include benzodiazepine receptor agonists (zolpide …
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
De Crescenzo F, D'Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, Kurtulmus A, Tomlinson A, Mitrova Z, Foti F, Del Giovane C, Quested DJ, Cowen PJ, Barbui C, Amato L, Efthimiou O, Cipriani A. De Crescenzo F, et al. Lancet. 2022 Jul 16;400(10347):170-184. doi: 10.1016/S0140-6736(22)00878-9. Lancet. 2022. PMID: 35843245 Free article.
Benzodiazepines, eszopiclone, zolpidem, and zopiclone were more efficacious than melatonin, ramelteon, and zaleplon (SMD 0.27-0.71 [moderate to very low]). Intermediate-acting benzodiazepines, long-acting benzodiazepines, and eszopiclone had fewer discontinuations due to a …
Benzodiazepines, eszopiclone, zolpidem, and zopiclone were more efficacious than melatonin, ramelteon, and zaleplon (SMD 0.27-0.71 [m …
Zaleplon.
Foda NH, Bakhaidar RB. Foda NH, et al. Profiles Drug Subst Excip Relat Methodol. 2010;35:347-71. doi: 10.1016/S1871-5125(10)35008-4. Epub 2010 Mar 15. Profiles Drug Subst Excip Relat Methodol. 2010. PMID: 22469226 No abstract available.
Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
Weitzel KW, Wickman JM, Augustin SG, Strom JG. Weitzel KW, et al. Clin Ther. 2000 Nov;22(11):1254-67. doi: 10.1016/s0149-2918(00)83024-6. Clin Ther. 2000. PMID: 11117652 Review.
Zaleplon can be taken < or = 2 hours before awakening without "hangover" effects. ...Zaleplon has not been studied in pregnant women or children. The dose of zaleplon should be individualized; the recommended daily dose for most adults is 10 mg. ...
Zaleplon can be taken < or = 2 hours before awakening without "hangover" effects. ...Zaleplon has not been studied in pregn …
Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
Abad VC, Guilleminault C. Abad VC, et al. Drugs Aging. 2018 Sep;35(9):791-817. doi: 10.1007/s40266-018-0569-8. Drugs Aging. 2018. PMID: 30058034 Review.
This review focuses on Food and Drug Administration (FDA)-approved drugs for insomnia, including suvorexant, low-dose doxepin, Z-drugs (eszopiclone, zolpidem, zaleplon), benzodiazepines (triazolam, temazepam), and ramelteon. We review the indications, dosing, efficacy, ben …
This review focuses on Food and Drug Administration (FDA)-approved drugs for insomnia, including suvorexant, low-dose doxepin, Z-drugs (eszo …
Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
Heydorn WE. Heydorn WE. Expert Opin Investig Drugs. 2000 Apr;9(4):841-58. doi: 10.1517/13543784.9.4.841. Expert Opin Investig Drugs. 2000. PMID: 11060714 Review.
Preclinical studies have shown that the benzodiazepines triazolam and Ro17-1812 can substitute for zaleplon in animals trained to distinguish zaleplon from saline. The benzodiazepine antagonist flumazenil can antagonise the discriminative stimulus effect of zalep …
Preclinical studies have shown that the benzodiazepines triazolam and Ro17-1812 can substitute for zaleplon in animals trained to dis …
466 results

Searches related to "zaleplon"